CLINICAL_TRIALS ClinicalTrials.gov record update

A Dose Escalation and Dose Expansion Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma - CEP-2

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05100628
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:00.542518+00:00
Published At: 2025-01-06T00:00:00+00:00
Record Updated At: 2025-01-06
Results Posted At: 2025-01-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Soft-tissue Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-06"
protocolSection.identificationModule.nctId: "NCT05100628"
protocolSection.identificationModule.officialTitle: "A Dose Escalation and Dose Expansion Study of NOX66 Plus Doxorubicin in Anthracycline-na\u00efve, Adult Patients With Soft Tissue Sarcoma - CEP-2"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-01-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.